Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M McShane

Showing results (201-210 of 265) with videos related to

Pageof 27
Sort By:
Nature|October 18, 2013
Criteria for the use of omics-based predictors in clinical trialsLisa M McShane, Margaret M Cavenagh, Tracy G Lively, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2018
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused UpdateAntonio C Wolff, M Elizabeth Hale Hammond, Kimberly H Allison, et al.
JAMA Oncology|July 19, 2019
Association of Immune Marker Changes With Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple MyelomaOla Landgren, Jonathan N Hofmann, Charlene M McShane, et al.
Archives of Pathology & Laboratory Medicine|May 31, 2018
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused UpdateAntonio C Wolff, M Elizabeth Hale Hammond, Kimberly H Allison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 27, 2025
Ipatasertib in Patients with Tumors with AKT Mutations: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Sub-protocol Z1KCarolyn K McCourt, Zihan Wei, Kevin Kalinsky, et al.
JCO Precision Oncology|February 20, 2026
Larotrectinib in Patients With Tumors With <i>NTRK</i> Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-Z1ENeal Akhave, Zihe Song, David S Hong, et al.
Journal of the National Cancer Institute|November 9, 2013
An international Ki67 reproducibility studyMei-Yin C Polley, Samuel C Y Leung, Lisa M McShane, et al.
Plos One|July 30, 2015
Robustness of Next Generation Sequencing on Older Formalin-Fixed Paraffin-Embedded TissueDanielle Mercatante Carrick, Michele G Mehaffey, Michael C Sachs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 8, 2022
Phase II Study of Copanlisib in Patients With Tumors With <i>PIK3CA</i> Mutations: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1FSenthil Damodaran, Fengmin Zhao, Dustin A Deming, et al.
JCO Precision Oncology|December 12, 2024
Phase II Study of Sunitinib in Tumors With <i>c-KIT</i> Mutations: Results From the NCI MATCH ECOG-ACRIN Trial (EAY131) Subprotocol VLilian T Gien, Zihe Song, Andrew Poklepovic, et al.
Pageof 27

Showing results (201-210 of 265) with videos related to

Sort By:
Pageof 27
Nature|October 18, 2013
Criteria for the use of omics-based predictors in clinical trialsLisa M McShane, Margaret M Cavenagh, Tracy G Lively, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2018
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused UpdateAntonio C Wolff, M Elizabeth Hale Hammond, Kimberly H Allison, et al.
JAMA Oncology|July 19, 2019
Association of Immune Marker Changes With Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple MyelomaOla Landgren, Jonathan N Hofmann, Charlene M McShane, et al.
Archives of Pathology & Laboratory Medicine|May 31, 2018
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused UpdateAntonio C Wolff, M Elizabeth Hale Hammond, Kimberly H Allison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 27, 2025
Ipatasertib in Patients with Tumors with AKT Mutations: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Sub-protocol Z1KCarolyn K McCourt, Zihan Wei, Kevin Kalinsky, et al.
JCO Precision Oncology|February 20, 2026
Larotrectinib in Patients With Tumors With <i>NTRK</i> Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-Z1ENeal Akhave, Zihe Song, David S Hong, et al.
Journal of the National Cancer Institute|November 9, 2013
An international Ki67 reproducibility studyMei-Yin C Polley, Samuel C Y Leung, Lisa M McShane, et al.
Plos One|July 30, 2015
Robustness of Next Generation Sequencing on Older Formalin-Fixed Paraffin-Embedded TissueDanielle Mercatante Carrick, Michele G Mehaffey, Michael C Sachs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 8, 2022
Phase II Study of Copanlisib in Patients With Tumors With <i>PIK3CA</i> Mutations: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1FSenthil Damodaran, Fengmin Zhao, Dustin A Deming, et al.
JCO Precision Oncology|December 12, 2024
Phase II Study of Sunitinib in Tumors With <i>c-KIT</i> Mutations: Results From the NCI MATCH ECOG-ACRIN Trial (EAY131) Subprotocol VLilian T Gien, Zihe Song, Andrew Poklepovic, et al.
Pageof 27